Edward C Carlson
Overview
Explore the profile of Edward C Carlson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ren J, Privratsky J, Yang X, Dong F, Carlson E
Crit Care Med
. 2008 Jun;
36(7):2106-16.
PMID: 18552690
Objective: Antioxidant therapy has shown some promise in critical care medicine in which glutathione depletion and heart failure are often seen in critically ill patients. This study was designed to...
12.
Teiken J, Audettey J, Laturnus D, Zheng S, Epstein P, Carlson E
Anat Rec (Hoboken)
. 2007 Dec;
291(1):114-21.
PMID: 18085629
Recent studies show that podocyte nuclear density (N(V)) and numbers of renal podocytes per glomerulus (N) are altered in experimental and spontaneous diabetes mellitus. N(V) and N are generally reduced,...
13.
Relling D, Esberg L, Johnson W, Murphy E, Carlson E, Lukaski H, et al.
Obesity (Silver Spring)
. 2007 May;
15(5):1242-57.
PMID: 17495201
Objective: High-fat and marginally copper-deficient diets impair heart function, leading to cardiac hypertrophy, increased lipid droplet volume, and compromised contractile function, resembling lipotoxic cardiac dysfunction. However, the combined effect of...
14.
Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, El Refaey H, et al.
Curr Drug Targets
. 2006 Nov;
7(11):1513-29.
PMID: 17100591
Selegiline inhibits the activity of monoamine oxidase B, enhances the release of dopamine, blocks the uptake of dopamine, acts as a calmodulin antagonist, and enhances the level of cyclic AMP,...
15.
Relling D, Esberg L, Fang C, Johnson W, Murphy E, Carlson E, et al.
J Hypertens
. 2006 Feb;
24(3):549-61.
PMID: 16467659
Background: Obesity is associated with dyslipidemia, which leads to elevated triglyceride and ceramide levels, apoptosis and compromised cardiac function. Methods: To determine the role of high-fat diet-induced obesity on cardiomyocyte...
16.
Zheng S, Noonan W, Metreveli N, Coventry S, Kralik P, Carlson E, et al.
Diabetes
. 2004 Nov;
53(12):3248-57.
PMID: 15561957
OVE26 mice are a transgenic model of severe early-onset type 1 diabetes. These mice develop diabetes within the first weeks of life and can survive well over a year with...
17.
Carlson E, Vari R, Audette J, Finke M, Ressler M
Anat Rec A Discov Mol Cell Evol Biol
. 2004 Nov;
281(2):1308-18.
PMID: 15532046
The diabetic-prone BioBreeding Wistar rat (BB/DP) is an autoimmune model of insulin-dependent diabetes mellitus. Approximately 80-90% of the animals are hyperglycemic (BB/DP(h)) by 90-120 days of age while those that...
18.
Shavali S, Carlson E, Swinscoe J, Ebadi M
J Neurosci Res
. 2004 Apr;
76(4):563-71.
PMID: 15114628
1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, is known to cause parkinsonism in rodents and nonhuman primates. The levels of 1BnTIQ in cerebrospinal fluid of patients with Parkinson's disease (PD) were reported...
19.
Ye G, Metreveli N, Donthi R, Xia S, Xu M, Carlson E, et al.
Diabetes
. 2004 Apr;
53(5):1336-43.
PMID: 15111504
Many diabetic patients suffer from a cardiomyopathy that cannot be explained by poor coronary perfusion. Reactive oxygen species (ROS) have been proposed to contribute to this cardiomyopathy. Consistent with this...
20.
Sharma S, Carlson E, Ebadi M
J Neurocytol
. 2004 Jan;
32(4):329-43.
PMID: 14724376
We have examined mitochondrial membranes and molecular hallmarks of apoptosis in response to increasing concentrations of 1-Methyl, 4-phenyl, Pyridinium ion (MPP(+)) in SK-N-SH neurons and have evaluated the neuroprotective potential...